New eye injection trial aims to halt vision loss from diabetes and clots
Disease control
Recruiting now
This study is testing a new drug called ANXV to see if it is safe and might help people with two serious eye conditions: diabetic retinopathy and retinal vein occlusion. A small group of 12 adults will receive the drug as a slow injection into a vein for five days and be monitore…
Phase: PHASE2 • Sponsor: Annexin Pharmaceuticals AB • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC